• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Eitan Group appoints new Q Core Medical CEO

February 18, 2020 By Danielle Kirsh

eitan-group-logoEitan Group today said it appointed Igal Shany as CEO of its Q Core Medical and president of Eitan Group.

Shany has previously served on the board of directors for Q Core and sites on the board for Eitan’s other infusion companies Sorrel Medical and Avoset Health.

“I’ve had the pleasure of working with Eitan Group for more than 10 years and knowing Boaz Eitan for 20,” Shany said in a news release. “I’m excited to take a larger role with Eitan Group in order to add my operational and business experience to a group that is bringing innovative new products to market which can improve care delivery to patients in hospitals and at home. Our focus is on serving our customers and improving patient outcomes while making the lives of healthcare professionals easier.”

Prior to joining the Eitan Group, Shany was CFO of Saigon and most recently served as CFO of Kenshoo. He has also held a number of leadership roles at Spansion and Siemens Solar.

“We’re excited that Igal will be expanding his role with Eitan Group,” Boaz Eitan, chairman of the board for Eitan Group, said. “We know the vision, creativity and work ethic that Igal brings from years of working together. His expertise in business development and marketing experience has guided companies through to rapid expansion. With our growth in North America and Europe, his experience will be invaluable in establishing Eitan Group’s position as a leader in the infusion industry.”

Filed Under: Business/Financial News Tagged With: Eitan Group

IN CASE YOU MISSED IT

  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS